Misoprostol oral - Azanta

Drug Profile

Misoprostol oral - Azanta

Alternative Names: Angusta; PGE1

Latest Information Update: 21 Dec 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Azanta
  • Class Abortifacients; Antiulcers; Oxytocics; Prostaglandins
  • Mechanism of Action Prostaglandin E1 agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Registered Labour induction

Most Recent Events

  • 18 Dec 2017 Registered for Labour induction in Croatia, Slovenia, Hungary, Slovakia, Czech Republic, Bulgaria, Romania, Poland, Estonia, Latvia, France (PO)
  • 24 Aug 2017 Haemologic agree to distribute Azanta's misoprostol in United kingdom for Head and neck cancer
  • 15 Mar 2017 Registered for Labour induction in Finland, Iceland, Norway, Sweden, Denmark (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top